Pramodini Medicare Limited
SMEPRAMODINI • BSE, NSE
Issue details
Price band
₹110 - ₹118
Lot size
1,200 shares
Issue size
₹52.99 Cr
Min. investment
₹1,41,600
Registrar
Purva Sharegistry (India)
Grey market premium
N/A
Save your family's PANs once and check allotment for everyone the moment results are out.
Sign in with a mobile OTP. It takes 20 seconds.
IPO Timeline
Open
12 Aug
Close
14 Aug
Allotment
17 Aug
Listing
19 Aug
- Refunds & demat credit
- 18 Aug 2026
- Mandate end
- 29 Aug 2026
We calculate these dates from the allotment and close dates, so please treat them as indicative.
Application size
| Category | Minimum | Maximum |
|---|---|---|
| Retail | 1,200shares 1 lot · ₹1,41,600 | 1,200shares 1 lot · ₹1,41,600 |
| HNI | 2,400shares 2 lots · ₹2,83,200 | No limit funds permitting |
Based on the upper price band of ₹118 and a lot of 1,200 shares.
Subscription
| Quota | Shares offered | Shares bid | Applications | Subscribed |
|---|---|---|---|---|
| Total | — | 1,64,31,600 | 3,689 | — |
Last updated 26 days ago.
Issue structure
Face value
₹10 per share
Issue type
Bookbuilding IPO
Sale type
Fresh capital cum OFS
Fresh issue
₹59 Cr
50,14,800 shares
Offer for sale
₹6 Cr
5,00,400 shares
Shares pre-issue
1,66,94,795
Shares post-issue
2,20,45,595
Valuation & ratios
| Metric | Pre-IPO | Post-IPO |
|---|---|---|
| EPS | 10.41 | 7.88 |
| P/E | 11.34 | 14.97 |
| Market cap | ₹197Cr. | ₹260.14 Cr |
| KPI | Mar 31, 2026 |
|---|---|
| ROE | 39.08% |
| ROCE | 34.66% |
| Debt/Equity | 0.34 |
| RoNW | 32.69% |
| PAT Margin | 27.90% |
| EBITDA Margin | 49.61% |
| NAV | 31.84 |
| Price to Book Value | 3.71 |
Financials
| Metric | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Total income | 63.38 | 38.55 | 35.79 |
| Profit after tax | 17.38 | 11.14 | 7.14 |
| EBITDA | 30.9 | 20.97 | 15.53 |
| Net worth | 53.15 | 35.77 | 24.75 |
| Assets | 93.62 | 56.45 | 48.78 |
| Reserves & surplus | 36.46 | 34.49 | 23.46 |
| Total borrowing | 17.85 | 10.81 | 11.96 |
Figures in ₹ crore, as reported by the company in its offer document.
Objects of the issue
- 1.Funding of capital expenditure for purchase of Medical Equipments towards Existing and Proposed Diagnostic Centres₹45.15 Cr
- 2.General corporate purposes and unidentified inorganic acquisition—
What the company says it intends to do with the money raised.
Recent comparable IPOs
| Company | Issue price | P/E | Listing close | Listing gain |
|---|---|---|---|---|
| Modern Diagnostic & Research Centre Ltd.SME | ₹90 | 11.04 | ₹94.99 | +5.54% |
| Invicta Diagnostic Ltd.SME | ₹85 | 14.51 | ₹96.70 | +13.76% |
| Gaudium IVF & Women Health Ltd.Mainboard | ₹79 | 25.36 | ₹80.26 | +1.59% |
| Nephrocare Health Services Ltd.Mainboard | ₹460 | 63.52 | ₹471.25 | +2.45% |
Past listing performance of comparable issues. This is not a forecast: listing gains vary widely and can turn negative.
Issue fundamentals compiled from the company's offer document via Chittorgarh, last read 10 Aug 2026. Always verify against the RHP before applying.